nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Sorafenib—liver cancer	0.0111	0.543	CbGbCtD
Levobupivacaine—CYP3A4—Sorafenib—liver cancer	0.00582	0.284	CbGbCtD
Levobupivacaine—Infestation—Sorafenib—liver cancer	0.0053	0.00708	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Sorafenib—liver cancer	0.00519	0.00694	CcSEcCtD
Levobupivacaine—Hypokinesia—Epirubicin—liver cancer	0.00518	0.00693	CcSEcCtD
Levobupivacaine—Paralysis—Epirubicin—liver cancer	0.00504	0.00673	CcSEcCtD
Levobupivacaine—Ileus—Epirubicin—liver cancer	0.00494	0.00661	CcSEcCtD
Levobupivacaine—Hypokinesia—Doxorubicin—liver cancer	0.0048	0.00641	CcSEcCtD
Levobupivacaine—Ventricular arrhythmia—Epirubicin—liver cancer	0.00473	0.00632	CcSEcCtD
Levobupivacaine—Paralysis—Doxorubicin—liver cancer	0.00466	0.00623	CcSEcCtD
Levobupivacaine—Ileus—Doxorubicin—liver cancer	0.00457	0.00611	CcSEcCtD
Levobupivacaine—Fungal infection—Epirubicin—liver cancer	0.00453	0.00606	CcSEcCtD
Levobupivacaine—Feeling hot—Epirubicin—liver cancer	0.00446	0.00596	CcSEcCtD
Levobupivacaine—Tinnitus—Sorafenib—liver cancer	0.00443	0.00592	CcSEcCtD
Levobupivacaine—Flushing—Sorafenib—liver cancer	0.00441	0.0059	CcSEcCtD
Levobupivacaine—Cardiac disorder—Sorafenib—liver cancer	0.00441	0.0059	CcSEcCtD
Levobupivacaine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00437	0.00585	CcSEcCtD
Levobupivacaine—Rigors—Epirubicin—liver cancer	0.00429	0.00573	CcSEcCtD
Levobupivacaine—Arrhythmia—Sorafenib—liver cancer	0.00425	0.00568	CcSEcCtD
Levobupivacaine—Fungal infection—Doxorubicin—liver cancer	0.00419	0.0056	CcSEcCtD
Levobupivacaine—Mental disorder—Sorafenib—liver cancer	0.00417	0.00557	CcSEcCtD
Levobupivacaine—Malnutrition—Sorafenib—liver cancer	0.00414	0.00553	CcSEcCtD
Levobupivacaine—Erythema—Sorafenib—liver cancer	0.00414	0.00553	CcSEcCtD
Levobupivacaine—Feeling hot—Doxorubicin—liver cancer	0.00413	0.00551	CcSEcCtD
Levobupivacaine—Extravasation—Epirubicin—liver cancer	0.00401	0.00536	CcSEcCtD
Levobupivacaine—Breast pain—Epirubicin—liver cancer	0.00401	0.00536	CcSEcCtD
Levobupivacaine—Cardiovascular disorder—Epirubicin—liver cancer	0.00398	0.00532	CcSEcCtD
Levobupivacaine—Muscle spasms—Sorafenib—liver cancer	0.00398	0.00532	CcSEcCtD
Levobupivacaine—Rigors—Doxorubicin—liver cancer	0.00397	0.0053	CcSEcCtD
Levobupivacaine—Skin discolouration—Epirubicin—liver cancer	0.00387	0.00518	CcSEcCtD
Levobupivacaine—Bone disorder—Epirubicin—liver cancer	0.00387	0.00518	CcSEcCtD
Levobupivacaine—Ventricular extrasystoles—Epirubicin—liver cancer	0.00387	0.00518	CcSEcCtD
Levobupivacaine—Anaemia—Sorafenib—liver cancer	0.00383	0.00511	CcSEcCtD
Levobupivacaine—Hypocalcaemia—Epirubicin—liver cancer	0.00382	0.00511	CcSEcCtD
Levobupivacaine—Angioedema—Sorafenib—liver cancer	0.00378	0.00505	CcSEcCtD
Levobupivacaine—Syncope—Sorafenib—liver cancer	0.00371	0.00496	CcSEcCtD
Levobupivacaine—Extravasation—Doxorubicin—liver cancer	0.00371	0.00496	CcSEcCtD
Levobupivacaine—Breast pain—Doxorubicin—liver cancer	0.00371	0.00496	CcSEcCtD
Levobupivacaine—Blood bilirubin increased—Epirubicin—liver cancer	0.0037	0.00494	CcSEcCtD
Levobupivacaine—Dysarthria—Epirubicin—liver cancer	0.0037	0.00494	CcSEcCtD
Levobupivacaine—Cardiovascular disorder—Doxorubicin—liver cancer	0.00368	0.00492	CcSEcCtD
Levobupivacaine—Loss of consciousness—Sorafenib—liver cancer	0.00364	0.00486	CcSEcCtD
Levobupivacaine—Cough—Sorafenib—liver cancer	0.00361	0.00483	CcSEcCtD
Levobupivacaine—Atrioventricular block—Epirubicin—liver cancer	0.00361	0.00482	CcSEcCtD
Levobupivacaine—Bone disorder—Doxorubicin—liver cancer	0.00358	0.00479	CcSEcCtD
Levobupivacaine—Skin discolouration—Doxorubicin—liver cancer	0.00358	0.00479	CcSEcCtD
Levobupivacaine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00358	0.00479	CcSEcCtD
Levobupivacaine—Hypertension—Sorafenib—liver cancer	0.00357	0.00478	CcSEcCtD
Levobupivacaine—Neck pain—Epirubicin—liver cancer	0.00354	0.00473	CcSEcCtD
Levobupivacaine—Hypocalcaemia—Doxorubicin—liver cancer	0.00354	0.00473	CcSEcCtD
Levobupivacaine—CYP3A4—Doxorubicin—liver cancer	0.00353	0.173	CbGbCtD
Levobupivacaine—Arthralgia—Sorafenib—liver cancer	0.00352	0.00471	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0035	0.00468	CcSEcCtD
Levobupivacaine—Ventricular tachycardia—Epirubicin—liver cancer	0.0035	0.00468	CcSEcCtD
Levobupivacaine—Hyperkalaemia—Epirubicin—liver cancer	0.00344	0.00459	CcSEcCtD
Levobupivacaine—Blood bilirubin increased—Doxorubicin—liver cancer	0.00342	0.00457	CcSEcCtD
Levobupivacaine—Dysarthria—Doxorubicin—liver cancer	0.00342	0.00457	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Sorafenib—liver cancer	0.00338	0.00451	CcSEcCtD
Levobupivacaine—Infection—Sorafenib—liver cancer	0.00336	0.00448	CcSEcCtD
Levobupivacaine—Atrioventricular block—Doxorubicin—liver cancer	0.00334	0.00446	CcSEcCtD
Levobupivacaine—Shock—Sorafenib—liver cancer	0.00332	0.00444	CcSEcCtD
Levobupivacaine—Nervous system disorder—Sorafenib—liver cancer	0.00331	0.00443	CcSEcCtD
Levobupivacaine—Neuropathy—Epirubicin—liver cancer	0.00329	0.00439	CcSEcCtD
Levobupivacaine—Skin disorder—Sorafenib—liver cancer	0.00328	0.00438	CcSEcCtD
Levobupivacaine—Neck pain—Doxorubicin—liver cancer	0.00328	0.00438	CcSEcCtD
Levobupivacaine—Ventricular tachycardia—Doxorubicin—liver cancer	0.00324	0.00433	CcSEcCtD
Levobupivacaine—Hyperkalaemia—Doxorubicin—liver cancer	0.00318	0.00425	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Epirubicin—liver cancer	0.00311	0.00416	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00308	0.00411	CcSEcCtD
Levobupivacaine—Neuropathy—Doxorubicin—liver cancer	0.00304	0.00406	CcSEcCtD
Levobupivacaine—Dyspnoea—Sorafenib—liver cancer	0.00301	0.00402	CcSEcCtD
Levobupivacaine—Dyspepsia—Sorafenib—liver cancer	0.00297	0.00397	CcSEcCtD
Levobupivacaine—Decreased appetite—Sorafenib—liver cancer	0.00294	0.00392	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00292	0.0039	CcSEcCtD
Levobupivacaine—Constipation—Sorafenib—liver cancer	0.00289	0.00386	CcSEcCtD
Levobupivacaine—Pain—Sorafenib—liver cancer	0.00289	0.00386	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Doxorubicin—liver cancer	0.00288	0.00385	CcSEcCtD
Levobupivacaine—Vascular purpura—Epirubicin—liver cancer	0.00284	0.00379	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Sorafenib—liver cancer	0.00276	0.00369	CcSEcCtD
Levobupivacaine—Urticaria—Sorafenib—liver cancer	0.00268	0.00359	CcSEcCtD
Levobupivacaine—Abdominal pain—Sorafenib—liver cancer	0.00267	0.00357	CcSEcCtD
Levobupivacaine—Body temperature increased—Sorafenib—liver cancer	0.00267	0.00357	CcSEcCtD
Levobupivacaine—Purpura—Epirubicin—liver cancer	0.00264	0.00352	CcSEcCtD
Levobupivacaine—Vascular purpura—Doxorubicin—liver cancer	0.00263	0.00351	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00262	0.00351	CcSEcCtD
Levobupivacaine—Lethargy—Epirubicin—liver cancer	0.00259	0.00346	CcSEcCtD
Levobupivacaine—Osteoarthritis—Epirubicin—liver cancer	0.00254	0.00339	CcSEcCtD
Levobupivacaine—Diplopia—Epirubicin—liver cancer	0.00254	0.00339	CcSEcCtD
Levobupivacaine—Hypersensitivity—Sorafenib—liver cancer	0.00249	0.00333	CcSEcCtD
Levobupivacaine—Purpura—Doxorubicin—liver cancer	0.00244	0.00326	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00243	0.00324	CcSEcCtD
Levobupivacaine—Asthenia—Sorafenib—liver cancer	0.00242	0.00324	CcSEcCtD
Levobupivacaine—Cardiac arrest—Epirubicin—liver cancer	0.00242	0.00323	CcSEcCtD
Levobupivacaine—Lethargy—Doxorubicin—liver cancer	0.0024	0.0032	CcSEcCtD
Levobupivacaine—Pruritus—Sorafenib—liver cancer	0.00239	0.00319	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Epirubicin—liver cancer	0.00238	0.00318	CcSEcCtD
Levobupivacaine—Osteoarthritis—Doxorubicin—liver cancer	0.00235	0.00314	CcSEcCtD
Levobupivacaine—Diplopia—Doxorubicin—liver cancer	0.00235	0.00314	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Epirubicin—liver cancer	0.00232	0.0031	CcSEcCtD
Levobupivacaine—Diarrhoea—Sorafenib—liver cancer	0.00231	0.00309	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00229	0.00306	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00224	0.00299	CcSEcCtD
Levobupivacaine—Muscular weakness—Epirubicin—liver cancer	0.00224	0.00299	CcSEcCtD
Levobupivacaine—Cardiac arrest—Doxorubicin—liver cancer	0.00223	0.00299	CcSEcCtD
Levobupivacaine—Dizziness—Sorafenib—liver cancer	0.00223	0.00299	CcSEcCtD
Levobupivacaine—Abdominal distension—Epirubicin—liver cancer	0.00221	0.00295	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Doxorubicin—liver cancer	0.0022	0.00294	CcSEcCtD
Levobupivacaine—Dysphagia—Epirubicin—liver cancer	0.0022	0.00293	CcSEcCtD
Levobupivacaine—Vomiting—Sorafenib—liver cancer	0.00215	0.00287	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00215	0.00287	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00212	0.00283	CcSEcCtD
Levobupivacaine—Headache—Sorafenib—liver cancer	0.00212	0.00283	CcSEcCtD
Levobupivacaine—Muscular weakness—Doxorubicin—liver cancer	0.00207	0.00277	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00207	0.00277	CcSEcCtD
Levobupivacaine—Abdominal distension—Doxorubicin—liver cancer	0.00204	0.00273	CcSEcCtD
Levobupivacaine—Dysphagia—Doxorubicin—liver cancer	0.00203	0.00271	CcSEcCtD
Levobupivacaine—Nausea—Sorafenib—liver cancer	0.00201	0.00268	CcSEcCtD
Levobupivacaine—Infestation NOS—Epirubicin—liver cancer	0.00196	0.00262	CcSEcCtD
Levobupivacaine—Infestation—Epirubicin—liver cancer	0.00196	0.00262	CcSEcCtD
Levobupivacaine—Drowsiness—Epirubicin—liver cancer	0.00196	0.00262	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Epirubicin—liver cancer	0.00192	0.00256	CcSEcCtD
Levobupivacaine—Urinary tract infection—Epirubicin—liver cancer	0.0019	0.00254	CcSEcCtD
Levobupivacaine—Sweating—Epirubicin—liver cancer	0.00188	0.00251	CcSEcCtD
Levobupivacaine—Haematuria—Epirubicin—liver cancer	0.00187	0.00249	CcSEcCtD
Levobupivacaine—Drowsiness—Doxorubicin—liver cancer	0.00181	0.00242	CcSEcCtD
Levobupivacaine—Infestation—Doxorubicin—liver cancer	0.00181	0.00242	CcSEcCtD
Levobupivacaine—Infestation NOS—Doxorubicin—liver cancer	0.00181	0.00242	CcSEcCtD
Levobupivacaine—Bradycardia—Epirubicin—liver cancer	0.00179	0.00239	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Doxorubicin—liver cancer	0.00178	0.00237	CcSEcCtD
Levobupivacaine—Urinary tract infection—Doxorubicin—liver cancer	0.00176	0.00235	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Epirubicin—liver cancer	0.00175	0.00234	CcSEcCtD
Levobupivacaine—Sweating—Doxorubicin—liver cancer	0.00174	0.00232	CcSEcCtD
Levobupivacaine—Oedema peripheral—Epirubicin—liver cancer	0.00173	0.00231	CcSEcCtD
Levobupivacaine—Haematuria—Doxorubicin—liver cancer	0.00173	0.00231	CcSEcCtD
Levobupivacaine—Bradycardia—Doxorubicin—liver cancer	0.00166	0.00221	CcSEcCtD
Levobupivacaine—Tinnitus—Epirubicin—liver cancer	0.00164	0.00219	CcSEcCtD
Levobupivacaine—Flushing—Epirubicin—liver cancer	0.00163	0.00218	CcSEcCtD
Levobupivacaine—Cardiac disorder—Epirubicin—liver cancer	0.00163	0.00218	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Doxorubicin—liver cancer	0.00162	0.00216	CcSEcCtD
Levobupivacaine—Oedema peripheral—Doxorubicin—liver cancer	0.0016	0.00214	CcSEcCtD
Levobupivacaine—Chills—Epirubicin—liver cancer	0.00158	0.00211	CcSEcCtD
Levobupivacaine—Arrhythmia—Epirubicin—liver cancer	0.00157	0.0021	CcSEcCtD
Levobupivacaine—Mental disorder—Epirubicin—liver cancer	0.00154	0.00206	CcSEcCtD
Levobupivacaine—Erythema—Epirubicin—liver cancer	0.00153	0.00204	CcSEcCtD
Levobupivacaine—Malnutrition—Epirubicin—liver cancer	0.00153	0.00204	CcSEcCtD
Levobupivacaine—Tinnitus—Doxorubicin—liver cancer	0.00152	0.00203	CcSEcCtD
Levobupivacaine—Cardiac disorder—Doxorubicin—liver cancer	0.00151	0.00202	CcSEcCtD
Levobupivacaine—Flushing—Doxorubicin—liver cancer	0.00151	0.00202	CcSEcCtD
Levobupivacaine—Flatulence—Epirubicin—liver cancer	0.00151	0.00201	CcSEcCtD
Levobupivacaine—Tension—Epirubicin—liver cancer	0.0015	0.00201	CcSEcCtD
Levobupivacaine—Nervousness—Epirubicin—liver cancer	0.00149	0.00199	CcSEcCtD
Levobupivacaine—Back pain—Epirubicin—liver cancer	0.00148	0.00198	CcSEcCtD
Levobupivacaine—Muscle spasms—Epirubicin—liver cancer	0.00147	0.00197	CcSEcCtD
Levobupivacaine—Chills—Doxorubicin—liver cancer	0.00146	0.00195	CcSEcCtD
Levobupivacaine—Arrhythmia—Doxorubicin—liver cancer	0.00145	0.00194	CcSEcCtD
Levobupivacaine—Vision blurred—Epirubicin—liver cancer	0.00144	0.00193	CcSEcCtD
Levobupivacaine—Mental disorder—Doxorubicin—liver cancer	0.00142	0.0019	CcSEcCtD
Levobupivacaine—Erythema—Doxorubicin—liver cancer	0.00142	0.00189	CcSEcCtD
Levobupivacaine—Malnutrition—Doxorubicin—liver cancer	0.00142	0.00189	CcSEcCtD
Levobupivacaine—Anaemia—Epirubicin—liver cancer	0.00141	0.00189	CcSEcCtD
Levobupivacaine—Agitation—Epirubicin—liver cancer	0.00141	0.00188	CcSEcCtD
Levobupivacaine—Flatulence—Doxorubicin—liver cancer	0.00139	0.00186	CcSEcCtD
Levobupivacaine—Tension—Doxorubicin—liver cancer	0.00139	0.00186	CcSEcCtD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00138	0.00596	CbGpPWpGaD
Levobupivacaine—Nervousness—Doxorubicin—liver cancer	0.00137	0.00184	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—TRIO—liver cancer	0.00137	0.00593	CbGpPWpGaD
Levobupivacaine—Syncope—Epirubicin—liver cancer	0.00137	0.00183	CcSEcCtD
Levobupivacaine—Back pain—Doxorubicin—liver cancer	0.00137	0.00183	CcSEcCtD
Levobupivacaine—Muscle spasms—Doxorubicin—liver cancer	0.00136	0.00182	CcSEcCtD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00136	0.00588	CbGpPWpGaD
Levobupivacaine—Palpitations—Epirubicin—liver cancer	0.00135	0.00181	CcSEcCtD
Levobupivacaine—Loss of consciousness—Epirubicin—liver cancer	0.00134	0.0018	CcSEcCtD
Levobupivacaine—Cough—Epirubicin—liver cancer	0.00133	0.00178	CcSEcCtD
Levobupivacaine—Vision blurred—Doxorubicin—liver cancer	0.00133	0.00178	CcSEcCtD
Levobupivacaine—Convulsion—Epirubicin—liver cancer	0.00133	0.00177	CcSEcCtD
Levobupivacaine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00132	0.00572	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TRIO—liver cancer	0.00132	0.00572	CbGpPWpGaD
Levobupivacaine—Hypertension—Epirubicin—liver cancer	0.00132	0.00176	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00131	0.00567	CbGpPWpGaD
Levobupivacaine—Anaemia—Doxorubicin—liver cancer	0.00131	0.00175	CcSEcCtD
Levobupivacaine—Arthralgia—Epirubicin—liver cancer	0.0013	0.00174	CcSEcCtD
Levobupivacaine—Agitation—Doxorubicin—liver cancer	0.0013	0.00174	CcSEcCtD
Levobupivacaine—Anxiety—Epirubicin—liver cancer	0.0013	0.00173	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00129	0.00173	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—TCF4—liver cancer	0.00129	0.00558	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00129	0.00556	CbGpPWpGaD
Levobupivacaine—Syncope—Doxorubicin—liver cancer	0.00127	0.0017	CcSEcCtD
Levobupivacaine—Confusional state—Epirubicin—liver cancer	0.00126	0.00168	CcSEcCtD
Levobupivacaine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00125	0.00543	CbGpPWpGaD
Levobupivacaine—Palpitations—Doxorubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Levobupivacaine—Oedema—Epirubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Epirubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Levobupivacaine—Loss of consciousness—Doxorubicin—liver cancer	0.00124	0.00166	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—TCF4—liver cancer	0.00124	0.00538	CbGpPWpGaD
Levobupivacaine—Infection—Epirubicin—liver cancer	0.00124	0.00166	CcSEcCtD
Levobupivacaine—Cough—Doxorubicin—liver cancer	0.00124	0.00165	CcSEcCtD
Levobupivacaine—Shock—Epirubicin—liver cancer	0.00123	0.00164	CcSEcCtD
Levobupivacaine—Convulsion—Doxorubicin—liver cancer	0.00123	0.00164	CcSEcCtD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00123	0.0053	CbGpPWpGaD
Levobupivacaine—Nervous system disorder—Epirubicin—liver cancer	0.00122	0.00164	CcSEcCtD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00122	0.00529	CbGpPWpGaD
Levobupivacaine—Hypertension—Doxorubicin—liver cancer	0.00122	0.00163	CcSEcCtD
Levobupivacaine—Tachycardia—Epirubicin—liver cancer	0.00122	0.00163	CcSEcCtD
Levobupivacaine—Skin disorder—Epirubicin—liver cancer	0.00121	0.00162	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Epirubicin—liver cancer	0.00121	0.00161	CcSEcCtD
Levobupivacaine—Arthralgia—Doxorubicin—liver cancer	0.0012	0.00161	CcSEcCtD
Levobupivacaine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.0012	0.0052	CbGpPWpGaD
Levobupivacaine—Anxiety—Doxorubicin—liver cancer	0.0012	0.0016	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0012	0.0016	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—UGDH—liver cancer	0.00117	0.00505	CbGpPWpGaD
Levobupivacaine—Hypotension—Epirubicin—liver cancer	0.00117	0.00156	CcSEcCtD
Levobupivacaine—Confusional state—Doxorubicin—liver cancer	0.00116	0.00156	CcSEcCtD
Levobupivacaine—Oedema—Doxorubicin—liver cancer	0.00116	0.00154	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Doxorubicin—liver cancer	0.00116	0.00154	CcSEcCtD
Levobupivacaine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00115	0.00499	CbGpPWpGaD
Levobupivacaine—Infection—Doxorubicin—liver cancer	0.00115	0.00153	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTA3—liver cancer	0.00115	0.00496	CbGpPWpGaD
Levobupivacaine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00114	0.00152	CcSEcCtD
Levobupivacaine—Shock—Doxorubicin—liver cancer	0.00114	0.00152	CcSEcCtD
Levobupivacaine—Nervous system disorder—Doxorubicin—liver cancer	0.00113	0.00151	CcSEcCtD
Levobupivacaine—CYP1A2—Estrogen Receptor Pathway—JUN—liver cancer	0.00113	0.00489	CbGpPWpGaD
Levobupivacaine—Insomnia—Epirubicin—liver cancer	0.00113	0.00151	CcSEcCtD
Levobupivacaine—Tachycardia—Doxorubicin—liver cancer	0.00113	0.00151	CcSEcCtD
Levobupivacaine—Skin disorder—Doxorubicin—liver cancer	0.00112	0.0015	CcSEcCtD
Levobupivacaine—Paraesthesia—Epirubicin—liver cancer	0.00112	0.0015	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—HNF4A—liver cancer	0.00112	0.00484	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Doxorubicin—liver cancer	0.00112	0.00149	CcSEcCtD
Levobupivacaine—Dyspnoea—Epirubicin—liver cancer	0.00111	0.00149	CcSEcCtD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00111	0.0048	CbGpPWpGaD
Levobupivacaine—Somnolence—Epirubicin—liver cancer	0.00111	0.00148	CcSEcCtD
Levobupivacaine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00111	0.0048	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.00111	0.00479	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Epirubicin—liver cancer	0.0011	0.00147	CcSEcCtD
Levobupivacaine—Decreased appetite—Epirubicin—liver cancer	0.00109	0.00145	CcSEcCtD
Levobupivacaine—Hypotension—Doxorubicin—liver cancer	0.00108	0.00144	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—HNF4A—liver cancer	0.00108	0.00466	CbGpPWpGaD
Levobupivacaine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00108	0.00144	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—CYP2E1—liver cancer	0.00107	0.00462	CbGpPWpGaD
Levobupivacaine—Pain—Epirubicin—liver cancer	0.00107	0.00143	CcSEcCtD
Levobupivacaine—Constipation—Epirubicin—liver cancer	0.00107	0.00143	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00105	0.00141	CcSEcCtD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00105	0.00454	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTA4—liver cancer	0.00105	0.00454	CbGpPWpGaD
Levobupivacaine—Insomnia—Doxorubicin—liver cancer	0.00104	0.0014	CcSEcCtD
Levobupivacaine—Paraesthesia—Doxorubicin—liver cancer	0.00104	0.00139	CcSEcCtD
Levobupivacaine—Dyspnoea—Doxorubicin—liver cancer	0.00103	0.00138	CcSEcCtD
Levobupivacaine—Feeling abnormal—Epirubicin—liver cancer	0.00103	0.00137	CcSEcCtD
Levobupivacaine—Somnolence—Doxorubicin—liver cancer	0.00103	0.00137	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTA2—liver cancer	0.00102	0.00442	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Epirubicin—liver cancer	0.00102	0.00136	CcSEcCtD
Levobupivacaine—Dyspepsia—Doxorubicin—liver cancer	0.00102	0.00136	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—ABL1—liver cancer	0.00101	0.00437	CbGpPWpGaD
Levobupivacaine—Decreased appetite—Doxorubicin—liver cancer	0.001	0.00134	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000997	0.00133	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000992	0.00429	CbGpPWpGaD
Levobupivacaine—Urticaria—Epirubicin—liver cancer	0.000992	0.00133	CcSEcCtD
Levobupivacaine—Pain—Doxorubicin—liver cancer	0.000988	0.00132	CcSEcCtD
Levobupivacaine—Constipation—Doxorubicin—liver cancer	0.000988	0.00132	CcSEcCtD
Levobupivacaine—Abdominal pain—Epirubicin—liver cancer	0.000987	0.00132	CcSEcCtD
Levobupivacaine—Body temperature increased—Epirubicin—liver cancer	0.000987	0.00132	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTA1—liver cancer	0.000987	0.00427	CbGpPWpGaD
Levobupivacaine—CYP1A2—Estrogen Receptor Pathway—STAT3—liver cancer	0.000978	0.00423	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—NAT2—liver cancer	0.000975	0.00422	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—ABL1—liver cancer	0.000974	0.00421	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Doxorubicin—liver cancer	0.000952	0.00127	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000945	0.00126	CcSEcCtD
Levobupivacaine—Hypersensitivity—Epirubicin—liver cancer	0.00092	0.00123	CcSEcCtD
Levobupivacaine—Urticaria—Doxorubicin—liver cancer	0.000918	0.00123	CcSEcCtD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—GGT1—liver cancer	0.000917	0.00397	CbGpPWpGaD
Levobupivacaine—Body temperature increased—Doxorubicin—liver cancer	0.000913	0.00122	CcSEcCtD
Levobupivacaine—Abdominal pain—Doxorubicin—liver cancer	0.000913	0.00122	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000902	0.0039	CbGpPWpGaD
Levobupivacaine—Asthenia—Epirubicin—liver cancer	0.000896	0.0012	CcSEcCtD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000894	0.00387	CbGpPWpGaD
Levobupivacaine—Pruritus—Epirubicin—liver cancer	0.000883	0.00118	CcSEcCtD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000864	0.00374	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Epirubicin—liver cancer	0.000854	0.00114	CcSEcCtD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000852	0.00369	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Doxorubicin—liver cancer	0.000851	0.00114	CcSEcCtD
Levobupivacaine—Asthenia—Doxorubicin—liver cancer	0.000829	0.00111	CcSEcCtD
Levobupivacaine—Dizziness—Epirubicin—liver cancer	0.000826	0.0011	CcSEcCtD
Levobupivacaine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000824	0.00357	CbGpPWpGaD
Levobupivacaine—Pruritus—Doxorubicin—liver cancer	0.000817	0.00109	CcSEcCtD
Levobupivacaine—Vomiting—Epirubicin—liver cancer	0.000794	0.00106	CcSEcCtD
Levobupivacaine—Diarrhoea—Doxorubicin—liver cancer	0.00079	0.00106	CcSEcCtD
Levobupivacaine—Headache—Epirubicin—liver cancer	0.000782	0.00105	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.00078	0.00337	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.000767	0.00332	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.000767	0.00332	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.000767	0.00332	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—KDR—liver cancer	0.000765	0.00331	CbGpPWpGaD
Levobupivacaine—Dizziness—Doxorubicin—liver cancer	0.000764	0.00102	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—MET—liver cancer	0.000749	0.00324	CbGpPWpGaD
Levobupivacaine—Nausea—Epirubicin—liver cancer	0.000742	0.000991	CcSEcCtD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000739	0.0032	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—KDR—liver cancer	0.000738	0.00319	CbGpPWpGaD
Levobupivacaine—Vomiting—Doxorubicin—liver cancer	0.000734	0.000981	CcSEcCtD
Levobupivacaine—Headache—Doxorubicin—liver cancer	0.000724	0.000967	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—MET—liver cancer	0.000722	0.00312	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ABL1—liver cancer	0.000721	0.00312	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000718	0.00311	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.0007	0.00303	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ABL1—liver cancer	0.000695	0.00301	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00069	0.00298	CbGpPWpGaD
Levobupivacaine—Nausea—Doxorubicin—liver cancer	0.000686	0.000917	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.000683	0.00295	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.000671	0.0029	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000667	0.00288	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.000662	0.00286	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000658	0.00285	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000636	0.00275	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—MMP2—liver cancer	0.000625	0.0027	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00062	0.00268	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000614	0.00266	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000612	0.00265	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000605	0.00262	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—MMP2—liver cancer	0.000602	0.00261	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000598	0.00259	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000592	0.00256	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PPARA—liver cancer	0.000588	0.00254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000584	0.00252	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000577	0.0025	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000571	0.00247	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00057	0.00247	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PPARA—liver cancer	0.000567	0.00245	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000563	0.00243	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—RAF1—liver cancer	0.000553	0.00239	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—KDR—liver cancer	0.000546	0.00236	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MAPK14—liver cancer	0.000543	0.00235	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00054	0.00234	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MET—liver cancer	0.000535	0.00231	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—RAF1—liver cancer	0.000534	0.00231	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000527	0.00228	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—KDR—liver cancer	0.000527	0.00228	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000524	0.00227	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MAPK14—liver cancer	0.000523	0.00226	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000518	0.00224	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MET—liver cancer	0.000515	0.00223	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000511	0.00221	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000503	0.00218	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PPARG—liver cancer	0.000486	0.0021	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000482	0.00208	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000479	0.00207	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000479	0.00207	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000474	0.00205	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000473	0.00204	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000472	0.00204	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—MMP9—liver cancer	0.00047	0.00203	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PPARG—liver cancer	0.000468	0.00203	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000467	0.00202	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000462	0.002	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000456	0.00197	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—MMP9—liver cancer	0.000453	0.00196	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MMP2—liver cancer	0.000446	0.00193	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000445	0.00193	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.00044	0.00191	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000434	0.00188	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000432	0.00187	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000432	0.00187	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MMP2—liver cancer	0.00043	0.00186	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000423	0.00183	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000422	0.00182	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—VEGFA—liver cancer	0.000422	0.00182	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000411	0.00178	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—VEGFA—liver cancer	0.000407	0.00176	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000399	0.00173	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—RAF1—liver cancer	0.000395	0.00171	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000388	0.00168	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—RAF1—liver cancer	0.000381	0.00165	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000372	0.00161	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000369	0.0016	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000367	0.00159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000359	0.00155	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—KRAS—liver cancer	0.000358	0.00155	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000352	0.00152	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—KRAS—liver cancer	0.000346	0.0015	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CTNNB1—liver cancer	0.000342	0.00148	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000341	0.00148	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MMP9—liver cancer	0.000335	0.00145	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000331	0.00143	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.00033	0.00143	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CTNNB1—liver cancer	0.00033	0.00143	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MMP9—liver cancer	0.000323	0.0014	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000308	0.00133	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000308	0.00133	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000307	0.00133	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000306	0.00132	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—HRAS—liver cancer	0.000305	0.00132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000302	0.00131	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—VEGFA—liver cancer	0.000301	0.0013	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—STAT3—liver cancer	0.000298	0.00129	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—HRAS—liver cancer	0.000294	0.00127	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6—liver cancer	0.000292	0.00126	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—VEGFA—liver cancer	0.00029	0.00126	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—STAT3—liver cancer	0.000287	0.00124	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000287	0.00124	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000283	0.00122	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000282	0.00122	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—IL6—liver cancer	0.000281	0.00122	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000278	0.0012	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TGFB1—liver cancer	0.000276	0.00119	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000272	0.00118	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000267	0.00116	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TGFB1—liver cancer	0.000266	0.00115	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000264	0.00114	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000264	0.00114	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000262	0.00113	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.00026	0.00112	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TNF—liver cancer	0.000258	0.00112	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—KRAS—liver cancer	0.000256	0.00111	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—liver cancer	0.000249	0.00108	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—KRAS—liver cancer	0.000247	0.00107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000237	0.00102	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000233	0.00101	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000218	0.000941	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—HRAS—liver cancer	0.000217	0.000941	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000215	0.000928	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—HRAS—liver cancer	0.00021	0.000907	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—liver cancer	0.000208	0.0009	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000206	0.000892	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000203	0.00088	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—liver cancer	0.000201	0.000868	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.0002	0.000867	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UGDH—liver cancer	0.0002	0.000864	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—liver cancer	0.000192	0.00083	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EPT1—liver cancer	0.000188	0.000813	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—liver cancer	0.000185	0.000801	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TAT—liver cancer	0.000178	0.00077	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000175	0.000758	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UGDH—liver cancer	0.000154	0.000667	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—EPT1—liver cancer	0.000145	0.000627	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TAT—liver cancer	0.000137	0.000595	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000131	0.000567	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CPT1B—liver cancer	0.000121	0.000524	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GLUL—liver cancer	0.000121	0.000524	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NR1H4—liver cancer	0.000117	0.000505	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA3—liver cancer	0.000115	0.000496	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA4—liver cancer	0.000105	0.000454	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000103	0.000444	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA2—liver cancer	0.000102	0.000442	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA1—liver cancer	9.87e-05	0.000427	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NAT2—liver cancer	9.76e-05	0.000422	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.38e-05	0.000406	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDOB—liver cancer	9.36e-05	0.000405	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CPT1B—liver cancer	9.34e-05	0.000404	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GLUL—liver cancer	9.34e-05	0.000404	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NR1H4—liver cancer	9.01e-05	0.00039	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CRABP1—liver cancer	8.93e-05	0.000386	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA3—liver cancer	8.86e-05	0.000383	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA4—liver cancer	8.1e-05	0.00035	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.04e-05	0.000348	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA2—liver cancer	7.9e-05	0.000342	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HPGDS—liver cancer	7.8e-05	0.000337	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.76e-05	0.000335	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA1—liver cancer	7.62e-05	0.000329	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NAT2—liver cancer	7.53e-05	0.000326	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDOB—liver cancer	7.22e-05	0.000312	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.06e-05	0.000306	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.97e-05	0.000302	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PSMD10—liver cancer	6.95e-05	0.000301	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PSMA4—liver cancer	6.95e-05	0.000301	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CRABP1—liver cancer	6.89e-05	0.000298	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT2—liver cancer	6.76e-05	0.000293	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2E1—liver cancer	6.36e-05	0.000275	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.16e-05	0.000266	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HPGDS—liver cancer	6.02e-05	0.00026	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYCS—liver cancer	5.95e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT1—liver cancer	5.84e-05	0.000253	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GGT1—liver cancer	5.84e-05	0.000253	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PSMD10—liver cancer	5.37e-05	0.000232	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PSMA4—liver cancer	5.37e-05	0.000232	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTP1—liver cancer	5.25e-05	0.000227	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT2—liver cancer	5.22e-05	0.000226	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMOX1—liver cancer	5.17e-05	0.000224	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.91e-05	0.000212	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—liver cancer	4.82e-05	0.000208	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYCS—liver cancer	4.59e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP1A1—liver cancer	4.57e-05	0.000198	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GGT1—liver cancer	4.51e-05	0.000195	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT1—liver cancer	4.51e-05	0.000195	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—liver cancer	4.26e-05	0.000184	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARA—liver cancer	4.18e-05	0.000181	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTP1—liver cancer	4.05e-05	0.000175	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMOX1—liver cancer	3.99e-05	0.000173	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.75e-05	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—liver cancer	3.72e-05	0.000161	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.58e-05	0.000155	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.53e-05	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARG—liver cancer	3.45e-05	0.000149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—liver cancer	3.29e-05	0.000142	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARA—liver cancer	3.23e-05	0.00014	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.15e-05	0.000136	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—liver cancer	3.11e-05	0.000134	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.76e-05	0.000119	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.74e-05	0.000119	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARG—liver cancer	2.67e-05	0.000115	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.43e-05	0.000105	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—liver cancer	2.4e-05	0.000104	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.12e-05	9.15e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.67e-05	7.23e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—liver cancer	1.37e-05	5.91e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.29e-05	5.58e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—liver cancer	1.05e-05	4.56e-05	CbGpPWpGaD
